Authorship of drug industry trials
- 12 June 2002
- journal article
- research article
- Published by Wiley in Pharmaceutical Statistics
- Vol. 1 (1), 5-7
- https://doi.org/10.1002/pst.11
Abstract
Viewpoint welcomes short papers expressing a personal opinion on matters of general interest to statisticians in the pharmaceutical industry. In this first issue Professor Stephen Senn shares his views on the authorship of drug industry trials. Copyright © 2002 John Wiley & Sons, Ltd.This publication has 8 references indexed in Scilit:
- Sponsorship, Authorship, and AccountabilityJAMA Otolaryngology–Head & Neck Surgery, 2001
- Sponsorship, Authorship, and AccountabilityAnnals of Internal Medicine, 2001
- Sponsorship, Authorship, and AccountabilityJAMA, 2001
- Sponsorship, Authorship, and AccountabilityNew England Journal of Medicine, 2001
- Sponsorship, authorship, and accountabilityThe Lancet, 2001
- Sponsorship, authorship and accountabilityThe Medical Journal of Australia, 2001
- Financiación, autoría y responsabilidadRevista Espanola de Cardiologia, 2001
- Being a modern pharmaceutical companyBMJ, 1998